Envision Healthcare Corporation (NYSE:EVHC)‘s stock had its “buy” rating reissued by stock analysts at Canaccord Genuity in a report issued on Thursday, The Fly reports. They currently have a $32.00 price target on the stock, down from their previous price target of $68.00. Canaccord Genuity’s target price indicates a potential downside of 24.88% from the stock’s current price.

Other analysts also recently issued research reports about the company. Jefferies Group LLC set a $71.00 price target on Envision Healthcare Corporation and gave the company a “buy” rating in a research note on Wednesday. Robert W. Baird reissued a “buy” rating and issued a $70.00 price target on shares of Envision Healthcare Corporation in a research note on Tuesday, October 17th. SunTrust Banks, Inc. set a $55.00 price target on Envision Healthcare Corporation and gave the company a “buy” rating in a research note on Sunday, October 15th. Bank of America Corporation dropped their price target on Envision Healthcare Corporation from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of Envision Healthcare Corporation in a research note on Monday, July 24th. Two analysts have rated the stock with a sell rating, five have given a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Envision Healthcare Corporation currently has an average rating of “Buy” and a consensus price target of $63.83.

Envision Healthcare Corporation (NYSE:EVHC) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). Envision Healthcare Corporation had a positive return on equity of 4.86% and a negative net margin of 6.39%. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. During the same period in the previous year, the business posted $1.13 EPS. The business’s quarterly revenue was up 142.0% compared to the same quarter last year.

Envision Healthcare Corporation announced that its board has initiated a share repurchase plan on Monday, September 18th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: “Envision Healthcare Corporation’s (EVHC) “Buy” Rating Reaffirmed at Canaccord Genuity” was first published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/11/02/envision-healthcare-corporations-evhc-buy-rating-reaffirmed-at-canaccord-genuity.html.

Several large investors have recently added to or reduced their stakes in EVHC. Teachers Advisors LLC increased its position in shares of Envision Healthcare Corporation by 1.0% in the first quarter. Teachers Advisors LLC now owns 329,462 shares of the company’s stock valued at $20,203,000 after acquiring an additional 3,230 shares during the last quarter. Paloma Partners Management Co increased its position in shares of Envision Healthcare Corporation by 37.6% in the first quarter. Paloma Partners Management Co now owns 8,514 shares of the company’s stock valued at $522,000 after acquiring an additional 2,328 shares during the last quarter. HighTower Advisors LLC increased its position in shares of Envision Healthcare Corporation by 5.6% in the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock valued at $274,000 after acquiring an additional 240 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Envision Healthcare Corporation in the first quarter valued at about $952,000. Finally, Xact Kapitalforvaltning AB increased its position in shares of Envision Healthcare Corporation by 1.8% in the second quarter. Xact Kapitalforvaltning AB now owns 14,627 shares of the company’s stock valued at $917,000 after acquiring an additional 258 shares during the last quarter.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

The Fly

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.